SDG 3 Newsletter: Diseases

To kick off 2025, we've mainly been discussing the third and fourth WHO targets for ensuring good health and well-being for all. These are to combat communicable diseases and to reduce mortality from non-communicable diseases (NCDs).
SDG 3 Newsletter: Diseases
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Use these links to navigate to a section! This newsletter covers:

Sickle Cell Disease and its impact on the Black community

Check out this interesting  blog written recently by members of Springer Nature's Black Employee Network. They focus on social, medical and policy approaches to improve the lives of those within the Black community affected by sickle cell disease.

Rare Disease Day

This Friday 28 February is Rare Disease Day. Read this blog to discover relevant journal articles, clinical trials, blogs and Q&As with researchers.

World Cancer Day: person-centred care

Read this blog on the new new 2025-2027 theme for World Cancer Day, ‘United by Unique.’ Here you can find related blogs, articles, Collections and clinical trials.

Don't forget to check out this blog on the highly-accessed Collection, Fibrosis and Cancer Intersection, published in Journal of Translational Medicine

Meet the Editors of Implementation Science Communications

Read Dr Elvin Geng's recent Q&A announcing his position as co-Editor-in-Chief of Implementation Science Communications. As an infectious disease physician involved in the public health HIV response and in AIDS research, Dr Geng discusses the current context in the US and the implications it may have for the global HIV response.

You can also read this Q&A for World AIDS Day, where Dr Aaloke Mody, Associate Editor, shares his experiences working in the fields of HIV and AIDS.

A history of Journal of Cannabis Research

Explore this blog on the history of Journal of Cannabis Research to learn about the use of medical cannabis in treating disease and improving symptoms.

HPV vaccination progress

Source: free Adobe Stock image

HPV Awareness Day is next week (4 March). Check out this blog that explains HPV vaccination progress and outlines areas for improvement in vaccination programmes.

Maternal and Neonatal Health webinar: sign up now

On 19 March we are hosting a free webinar on “Implementation of Evidence-Based Practices for Improving Maternal and Neonatal Health”. This webinar has some really interesting speakers, click the link to learn more and register.

Get involved! 

Thank you to everyone who contributed to this newsletter. If you are a researcher or colleague who would like to be involved with our SDG3 initiatives, get in touch. To be notified of future SDG3 newsletters, follow me, Alice Coe, on Research Communities. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Louis Gautier
3 months ago

This is all really cool, Alice! I've followed you so I can see all the new ones you send out :)

Go to the profile of Tamara May
3 months ago

Thanks for this, Alice. Great to see all the hard work being done by our Publishers, Editors, and Authors to help achieve the SDG3 targets!

Go to the profile of Alice Coe
2 months ago

Read our 2024 round-up newsletter here!

Follow the Topic

Public Health
Life Sciences > Health Sciences > Public Health
Reproductive Medicine
Life Sciences > Health Sciences > Clinical Medicine > Reproductive Medicine
Disease Prevention
Life Sciences > Health Sciences > Public Health > Health Promotion and Disease Prevention > Disease Prevention
Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases

Related Collections

With collections, you can get published faster and increase your visibility.

Mechanisms of action and potential therapeutic applications of the cannabis plant

This Special Collection of the Journal of Cannabis Research delves into the intricate world of cannabis, exploring the multifaceted mechanisms through which its diverse array of compounds interact with the human body and their potential therapeutic benefits. Cannabis, a plant with a long and complex history of human use, has garnered significant attention in recent years from the scientific community due to its potential to treat a wide range of medical conditions. This renewed interest has led to a surge in research aimed at elucidating the complex interplay between cannabis compounds and human physiology.

The Collection will focus on the following key areas:

• Phytochemical Diversity: A comprehensive examination of the various cannabinoids, terpenes, and flavonoids found in cannabis, exploring their individual properties and potential synergistic effects. This includes investigations into the unique chemical profiles of different cannabis chemovars and their potential therapeutic applications.

• Endocannabinoid System and non-endocannabinoid Interactions: A detailed analysis of how cannabis compounds interact with the endocannabinoid system and the broad range of receptors or neurotransmitters beyond the endocannabinoid system as well.

• Pharmacological Effects: An exploration of the diverse pharmacological effects of cannabis, including its analgesic, anti-inflammatory, anxiolytic, antiemetic, and neuroprotective properties. This includes preclinical and clinical studies investigating the therapeutic potential of cannabis for various conditions such as chronic pain, epilepsy, multiple sclerosis, anxiety disorders, and cancer.

• Therapeutic Applications: A critical evaluation of the current clinical evidence supporting the use of cannabis for specific medical conditions. This includes systematic reviews, meta-analyses, and randomized controlled clinical trials assessing the efficacy and safety of cannabis-based therapies.

• Drug Development and Delivery Systems: An examination of the latest advancements in cannabis-based drug development, including novel formulations, delivery systems, and personalized approaches to cannabis therapy. This includes research on synthetic cannabinoids, targeted drug delivery, and the development of standardized cannabis extracts.

Possible topics to be included:

• The role of the endocannabinoid system in health and disease

• The therapeutic potential of cannabinoids for neurological disorders

• Cannabis and mental health: implications for anxiety, depression, and PTSD

• The use of cannabis in palliative care and cancer treatment

• Cannabis-based drug development and clinical trials.

This Special Collection provides a comprehensive overview of the current state of knowledge regarding the mechanisms of action and potential therapeutic applications of the cannabis plant. By bringing together innovative research from leading experts in the field, we hope to stimulate further inquiry and contribute to the development of safe and effective cannabis-based therapies for the benefit of patients worldwide.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Oct 22, 2025

New developments in Cannabis sativa science: agronomy, plant biology, and molecular insights

This Collection focuses on the latest advancements in Cannabis sativa research, aiming to provide a comprehensive understanding of the key aspects that drive its production and utility. Cannabis, renowned for its diverse array of bioactive compounds, has garnered significant attention across scientific, agricultural, and industrial domains. This Collection invites original research, reviews, and perspectives on the following themes:

• Molecular Insights: exploring the genetic and transcriptomic mechanisms underlying cannabinoid and terpenoid biosynthesis, as well as glandular trichome development

• Germplasm Resources: studies on genetic diversity, breeding strategies, and innovative approaches for developing high-yield and specialized chemotype cultivars

• Plant Physiology: investigations into physiological responses to environmental stimuli, metabolic pathways, and signaling processes relevant to growth and secondary metabolite production

• Agronomic Practices: sustainable and optimized cultivation techniques, including light, nutrient, and stress management strategies, aimed at maximizing yield and quality in controlled and open-field systems.

This Collection serves as a platform for scientists, breeders, and industry stakeholders to share breakthroughs and collaborative insights. Together, these contributions will advance our understanding of cannabis biology and production, fostering innovation in this rapidly evolving field.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Ongoing